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Abstract
Background: Fetal alcohol syndrome (FAS) typically is observed among individuals with high 
prenatal alcohol exposures (PAE), but exposure histories obtained in clinical diagnostic settings 
are often inaccurate. The present analysis used the Lifestyle During Pregnancy Study (LDPS) to 
assess the potential effects of low-to-moderate average weekly alcohol consumption and binge 
drinking in early pregnancy on facial features associated with FAS among children 5 years of age.
Methods: The analysis is a prospective follow-up study of 670 women and their children 
sampled from the LDPS cohort based on maternal alcohol consumption during pregnancy. The 4-
Digit Code FAS Facial Photographic Analysis Software was used to measure the magnitude of 
expression of the 3 diagnostic facial features of FAS from standardized digital photographs. 
Logistic regression was used to estimate the odds of presenting with the FAS/partial fetal alcohol 
syndrome (PFAS) facial phenotypes relative to different patterns of prenatal alcohol exposure.
Results: Ten children presented with the FAS/PFAS facial phenotypes. None of the children 
sampled met the central nervous system (CNS) criteria for FAS or PFAS at age 5 years. All 
remained at risk for PFAS since some types of CNS dysfunction associated with this diagnosis 
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may only be assessed at older ages. The FAS/PFAS facial phenotypes were 8.5-fold more likely 
among children exposed to an average of 1 to 4 drinks/wk and 2.5-fold more likely among 
children with a single binge exposure in gestational weeks 3 to 4 compared to children with no 
such exposures. The magnitude of expression of the FAS facial phenotype was significantly 
correlated with all other diagnostic features of FAS: growth deficiency, microcephaly, and 
measures of CNS dysfunction.
Conclusions: These findings suggest that low-to-moderate levels of PAE or isolated binge 
exposures may place some fetuses at risk for FAS/PFAS. Thus, conservative advice is still for 
women to abstain from alcohol consumption during pregnancy.
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Disorders
Fetal alcohol syndrome (fas) is a permanent birth defect and developmental disability caused 
by in utero exposure to alcohol. FAS is characterized by growth deficiency, a unique 
constellation of minor facial anomalies, and structural, neurological, or functional central 
nervous system (CNS) abnormalities (Astley and Clarren, 2000; Bertrand et al., 2004; 
Stratton et al., 1996). Not all individuals exposed to and damaged by prenatal alcohol 
exposure have FAS, the most involved diagnosis under the umbrella of fetal alcohol 
spectrum disorders (FASDs). Prenatal exposure to alcohol can also result in more subtle 
adverse effects and diagnoses. The growth, facial, and CNS abnormalities can all present 
along separate continua from mild to severe (Stratton et al., 1996).
A number of FASD diagnostic schemes have been posed and applied worldwide (Astley, 
2004; Bertrand et al., 2004; Bower and Elliott, 2016; Cook et al., 2016; American 
Psychiatric Association, 2013; Hoyme et al., 2016). All promote an interdisciplinary 
approach to diagnosis and broadly agree that FASDs are characterized by growth, facial, and 
CNS abnormalities. But, the specific criteria used to define each diagnosis under the 
umbrella of FASDs do differ across the diagnostic systems (Astley, 2011; Astley et al., 2017; 
Coles et al., 2016). It should be noted that all schemes assess facial features for an FAS 
diagnosis since these features reflect anomalies in prenatal brain development. The current 
analysis used criteria as outlined in Astley (2004), also known as the 4-Digit Code. Briefly, 
these criteria require all of the following:
1. Growth deficiency: prenatal and/or postnatal height and/or weight at or below the 
10th percentile;
2. Facial dysmorphia: all 3 of the following: (i) short palpebral fissure lengths 
(PFLs; less than or equal to third percentile); (ii) smooth philtrum (Rank 4 or 5 
on the University of Washington Lip-Philtrum Guide); and (iii) thin upper lip 
(Rank 4 or 5 on the University of Washington Lip-Philtrum Guide);
3. Evidence of severe CNS structural, neurological, and/or functional 
abnormalities;
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4. Prenatal alcohol exposure: a confirmed or unknown history of exposure. FAS can 
be diagnosed in the absence of a confirmed prenatal alcohol exposure history if 
the 3 facial features (as defined by the Rank 4 facial phenotypes in the 4-Digit 
Code) are present. Empirical evidence confirms the Rank 4 facial phenotypes are 
so highly specific to (caused only by) prenatal alcohol exposure. Its presence can 
be used to confirm exposure when an exposure history is unavailable (Astley, 
2013).
The FAS facial phenotype is not simply present or absent. It presents along a clinically 
meaningful continuum from mild to moderate to severe (Astley and Clarren, 2000). The 
magnitude of expression of the FAS facial phenotype not only increases with increasing 
prenatal alcohol exposure, but also correlates significantly with increasing severity of growth 
deficiency, microcephaly, and CNS dysfunction (Astley, 2013). These significant 
correlations serve to validate a causal association between prenatal alcohol exposure and the 
growth, facial, and CNS abnormalities currently used to define FAS (Astley, 2013; Astley 
and Clarren, 2001).
FAS is typically observed among individuals with reportedly high prenatal alcohol 
exposures (PAE; ≥6 drinks/d or 5 to 6 drinks within a short period of time) (O’Leary and 
Bower, 2012), but exposure histories obtained in clinical diagnostic settings often are 
inaccurate. For example, the average reported exposure among 154 individuals diagnosed 
with FAS or partial fetal alcohol syndrome (PFAS) at the University of Washington FAS 
Diagnostic & Prevention Network (FASDPN) using the 4-Digit Code was 8 to 12 drinks per 
drinking occasion, 5 to 6 days per week (Astley, 2010). This average exposure pattern, 
however, spanned a wide range. At the low end of the range, 1 of every 14 children with 
FAS or PFAS had a reported exposure of no more than 1 drink/d. Are these 1 in 14 cases 
especially vulnerable to the adverse effects of prenatal alcohol exposure, or were their lower 
exposures inaccurately reported? The Lifestyle During Pregnancy Study (LDPS) (Kesmodel 
et al., 2010, 2012) provided just such a dataset that addressed this issue by collecting 
prenatal alcohol exposure history during early pregnancy and using standardized measures 
of growth, face, and CNS.
The LDPS has previously provided data on the association between low-to-moderate alcohol 
intake and alcohol binge drinking and neuropsychological development, including 
intelligence, attention, psychomotor function, executive function, and behavior (Bay et al., 
2012; Kesmodel et al., 2010, 2012, 2013). The objective of the present analysis was to use 
the LDPS to assess the potential effects of low-to-moderate average weekly alcohol 
consumption and binge drinking in early pregnancy on facial features associated with FAS 
among children 5 years of age. Specifically, we (i) document the occurrence of the 
individual FAS facial features and overall FAS facial phenotype in the study sample; (ii) 
assess the association between prenatal alcohol exposure and the magnitude of expression of 
the FAS facial features and phenotype; and (iii) assess the association between the 
magnitude of expression of the FAS facial phenotype and other diagnostic features of FAS, 
including cognitive impact, reduced head circumference, and growth deficiency.
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MATERIALS AND METHODS
Study Sample
This study was part of the LDPS, which has been described in detail elsewhere (Kesmodel et 
al., 2010, 2012). Briefly, the study is a prospective follow-up study based on a subsample 
from the Danish National Birth Cohort (DNBC; Olsen et al., 2001).
A total of 1,628 mother–child pairs participated in the follow-up. Inclusion was based on a 
stratified sample with oversampling of women with low-to-moderate alcohol intake and 
binge drinking (Kesmodel et al., 2010, 2012). Exclusion criteria were inability to speak 
Danish, impaired hearing or vision causing inability to complete the cognitive tests, multiple 
pregnancies, and congenital diseases likely to cause mental retardation (Kesmodel et al., 
2010). Data collection for the follow-up study took place from September 2003 to June 2008 
(Kesmodel et al., 2010).
Of the 1,628 participants’ images available for measurement, 670 met the inclusion criteria 
for this study and had at least 1 of the 3 facial features measured (see details in Appendix).
Exposure Assessment
Information on alcohol intake during pregnancy was derived from the first prenatal DNBC 
interview. Among the subsample of women participating in the follow-up, the median week 
of gestation for completing the prenatal interview was 17 weeks (range: 7 to 39 weeks). 
During the interview, the women were asked about their average number of beers, glasses of 
wine, and glasses of spirits they currently consumed at the time of the interview over the 
course of a week, and based on this information, the total number of weekly drinks was 
calculated. These alcohol exposure questions have been shown to yield valid estimates of 
alcohol consumption throughout pregnancy (relative to other methods) and reliable 
information among pregnant Danish women (Kesmodel and Olsen, 2001). Information on 
binge drinking during pregnancy included data on the number of binge episodes (defined as 
intake of ≥5 drinks on a single occasion) and the timing (gestational week) of these episodes 
(Kes-model, 2001) up until the time of the interview. A number of women in the current 
sample reported 1 or more binge episodes during early weeks of pregnancy, although their 
average number of drinks per week at the time of interview was zero (Kesmodel et al., 
2012). These women were classified accordingly as consuming zero average drinks per 
week during pregnancy, but with 1 or more previous binge episodes. The definition of a 
drink followed the definition from the Danish National Board of Health, with 1 standard 
drink being equal to 12 g of pure alcohol. The sampling stratification for average weekly 
consumption and binge consumption in the first trimester has been described previously 
(Kesmodel et al., 2010, 2012). This stratification resulted in 5 sampling categories used in 
this analysis.
Outcome Measures
Facial Features.—The follow-up assessments were conducted at 4 sites located in 
Copenhagen, Aarhus, Odense, and Aalborg. The assessment comprised a comprehensive 
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neuropsychological test battery which is described in detail elsewhere (Kesmodel et al., 
2010, 2012).
Following the test session, standardized digital facial photographs were taken of each mother 
and child to allow subsequent measurement of (dysmorphic) facial features, including the 
philtrum, the upper lip, and PFL. Specific procedures for taking and coding photographs are 
described in Appendix. All testers were blind to the exposure status of the participants, and 
all tests were administered in Danish.
Briefly, the University of Washington FAS Facial Photographic Analysis Software (Astley, 
2016) was used to measure the magnitude of expression of each of the 3 diagnostic facial 
features of FAS (short PFLs: 2 or more standard deviations (SD) below the mean; smooth 
philtrum (Rank 4 or 5 on the University of Washington Lip-Philtrum Guide) and thin upper 
lip (Rank 4 or 5 on the Lip-Philtrum Guide (Fig. 1), lip circularity ≥75.5) as defined by the 
University of Washington FASD 4-Digit Code (Astley, 2016). For the 366 children with 
photographs of sufficient quality to allow accurate measurement of all 3 facial features, the 
magnitude of expression of the overall FAS facial phenotype (Face Rank) was ranked on a 4-
point Likert scale (Rank 1: normal phenotype; Rank 2: mild FAS phenotype; Rank 3: 
moderate FAS phenotype; and Rank 4: severe FAS phenotype) in accordance with the FASD 
4-Digit Code (Astley, 2004). The Scandinavian PFL growth charts (Stromland et al., 1999) 
and University of Washington Lip-Philtrum Guide 1 were used for this Danish population.
Cognitive Function.—Child intelligence was assessed using the Wechsler Preschool and 
Primary Scale of Intelligence-Revised (WPPSI-R) (Wechsler, 1990) covering the age span 3 
to 7 years. The WPPSI-R includes 5 verbal and 5 performance subtests that are used to 
calculate an overall verbal intelligence quotient (VIQ), overall performance IQ (PIQ), and 
full-scale IQ (FSIQ). In this test battery, only 3 of the verbal (arithmetic, information, and 
vocabulary) and 3 of the performance (block design, geometric design, and object assembly) 
subtests were carried out to facilitate the child’s cooperation throughout the testing. Standard 
procedures were used to prorate scores from the shortened test.
Child attention was assessed with the Test of Everyday Attention for Children at Five 
(TEACh-5; Underbjerg et al., 2012, 2013) covering the age span 5 years to 5 years and 3 
months. For this study, 2 subtests assessing selective attention (“Great Balloon Hunt” and 
“Hide and Seek II”) and 2 subtests assessing sustained attention (“Barking” and “Draw a 
line”) were used. Each subtest score was standardized to a mean of 0 and a SD of 1. To 
calculate composite scores for overall, selective, and sustained attention, the means of the 
respective standardized subtest scores for each individual were calculated and restandardized 
to a mean of 0 and SD of 1.
Executive function was assessed using the Behavior Rating Inventory of Executive Function 
(BRIEF) questionnaire (Gioia et al., 2000) covering the age span 5 to 18 years. The 
questionnaire consists of 2 versions, 1 for parents and 1 for teachers. The parent version was 
used for these analyses because of higher participation. Each questionnaire evaluates 8 
domains of executive functioning and forms the Global Executive Composite (GEC). Three 
of the 8 domains form the Behavioral Regulation Index (BRI), and 5 of the domains form 
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the Metacognition Index (MI). Since the 8 domains do not follow a normal distribution, we 
performed a normalizing t-score transformation to standardize each domain to a mean of 50 
and SD of 10. To compute the GEC, BRI, and MI, the means of the respective domains for 
each individual were calculated and restandardized to a mean of 50 and SD of 10. For all 
BRIEF scores, a higher score indicates more executive function difficulties.
Covariates
Factors demonstrated in previous research to influence child neurodevelopment were 
selected as covariates. The following covariates were obtained in the prenatal interview and 
subsequently coded as follows: parity (0, 1, ≥2); prenatal smoking (yes/no); and maternal 
prepregnancy body mass index (BMI) (weight in kg/[height in m]2). At the time of the 5-
year follow-up, the following variables were recorded: maternal marital status (single at 
either the prenatal interview or follow-up/with partner at both times) and parental education 
in years (total duration of attained education averaged for both parents or maternal only if 
information on the father was missing). Additional information on collection of covariate 
information is provided elsewhere (Kesmodel, 2012; Kesmodel et al., 2010).
Maternal age was obtained from the unique Danish personal identification number, as were 
sex and age of the child. Birthweight in grams, head circumference, and gestational age in 
days were obtained from the Danish Medical Birth Registry (Bliddal et al., 2018).
Data Analysis
Descriptive statistics (i.e., means, SDs, and proportions) were used to profile the 
sociodemographics of the study population, the maternal drinking patterns, and the 
magnitude of expression of the FAS facial features and phenotype. Logistic regression was 
used to document the odds of presenting with the FAS/PFAS facial phenotype (Face Rank 3 
or 4), short PFLs (ABC-Score = C, 2 or more SDs below the mean), smooth philtrum (Rank 
4 or 5), or thin upper lip (Rank 4 or 5) relative to 4 different patterns of prenatal alcohol 
exposure: (i) average number of drinks/week during pregnancy (0, 1 to 4, ≥5), (ii) binge 
drinking (yes/no), (iii) number of binge drinking episodes (0, 1, 2 ≥ 3), and (iv) gestational 
timing of the single binge drinking episode (no binge, weeks 1 to 2, weeks 3 to 4, weeks 5+; 
multiple episodes). Odds ratios were adjusted for predefined covariates (parity; prenatal 
smoking; maternal prepregnancy BMI; maternal marital status; parental education in years; 
maternal age at the birth of the index child; sex and age of the child).
Not all photographs were of sufficient quality (e.g., facial expression, rotation, and focus) to 
generate accurate measures of all 3 facial features. As a result, participants were divided into 
2 groups. Group A (N = 366) consisted of children whose photographs were of sufficient 
quality to measure all 3 facial features. Group B (N = 670) consisted of children whose 
photographs were of sufficient quality to measure 1 to all 3 of the facial features. Group A is 
a subset of Group B. Group B was used for analyses focused on the individual facial 
features. Group A was used for analyses focused on the overall facial phenotype.
All analyses were conducted in SAS and Stata 12 (StataCorp LP, College Station, TX, USA) 
and weighted by sampling probabilities. Statistical tests were 2-sided and deemed significant 
at the 5% level. Estimates are accompanied by 95% confidence intervals.
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RESULTS
Sample Characteristics
Although the 2 subsets, Group A and Group B, were not randomly selected from the 1,628, 
the sociodemographic profiles (Table 1) and maternal drinking patterns (Table 2) confirm 
that both subgroups were highly reflective of one another and highly representative of the 
1,628 participants from which they were drawn. Of the 366 women in Group A, 308 (84%) 
reported, on average, low-to-moderate alcohol consumption with isolated episodes of binge 
drinking, and 58 reported no alcohol consumption during pregnancy. Of the 670 women in 
Group B, 561 (84%) reported, on average, low-to-moderate alcohol consumption with 
isolated episodes of binge drinking, and 109 reported no alcohol consumption during 
pregnancy (Table 2).
Occurrence of the FAS and PFAS Facial Phenotypes
Among the 366 participants with all 3 facial features measured, 308 had confirmed exposure 
to alcohol. Nine of the 308 (2.9%) met the 4-Digit Code criteria for the moderate expression 
of the FAS facial phenotype (Face Rank 3), and 1(0.3%) met the criteria for the severe 
expression of the FAS facial phenotype (Face Rank 4) (Table 3). Measures of growth, CNS 
structure and function, and maternal drinking patterns are presented in Table 4 to document 
whether any of these 10 children met the diagnostic criteria for FAS or PFAS in accordance 
with the FASD 4-Digit Code. All children were alcohol-exposed. Their mothers reported an 
average intake of 0 to 7 drinks/wk before pregnancy, 0 to 2 drinks on average per week 
during pregnancy, and a maximum of 1 binge episode during the first 20 weeks of 
pregnancy. All children were born at term. Five of the 10 presented with growth, head 
circumference, and/or IQ measures between 1 and 2 SDs below the mean. None of the 
children presented with growth measures at or below the 10th percentile. One child 
presented with a head circumference at the 10th percentile. In the absence of microcephaly 
(head circumference less than or equal to third percentile), FAS and PFAS require evidence 
of brain dysfunction. The level of brain dysfunction required for FAS or PFAS (CNS Rank 
3) is defined by the 4-Digit Code as 3 or more domains of brain function, 2 or more SDs 
below the mean based on a comprehensive assessment of language, memory, executive 
function, cognition, motor, attention, and adaptation, using validated instruments 
administered by clinical professionals (Astley, 2004). To confirm or rule out this level of 
brain dysfunction, these assessments must be administered when a child is old enough 
(typically >8 years) to engage in assessments of more complex, mature brain function 
(Astley, 2004). None of the 10 children met the above criteria for brain dysfunction based on 
the WPPSI-R IQ test. Thus, at 5 years of age, none of the 10 children met the 4-Digit Code 
CNS criteria for FAS or PFAS, but all remain at risk for PFAS because CNS dysfunction 
(CNS Rank 3) cannot be confirmed or ruled out at this young age.
Among the 304 children in which only 1 or 2 facial features could be measured, the full FAS 
facial phenotype (Face Rank 4) could effectively be ruled out in 96% and the moderate 
expression of FAS facial phenotype (Face Rank 3) could be ruled out in 77%. When 
combined with the facial outcomes of the 366 children with all 3 facial features measured, 
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the FAS/PFAS facial phenotypes (Face Ranks 3 to 4) could be ruled out in 96.7% of the 670 
children.
Occurrence of the Individual FAS Facial Features
Among the 670 participants with 1, 2, or all 3 of the facial features measured, 4% presented 
with PFLs 2 or more SDs below the mean (PFL ABC-Score = C), 11% presented with 
moderately-to-completely smooth philtrums (Philtrum Ranks 4 and 5; ABC-Score = C), and 
41% presented with moderately-to-severely thin upper lips (Lip Ranks 4 and 5; ABC-Score 
= C; Table 3; Fig. 1). The prevalence of each FAS facial feature was nearly identical in the 
smaller subset of 366 participants that had all 3 facial features measured.
Association Between FAS/PFAS Facial Features and Prenatal Alcohol Exposure
Table 5 shows the odds of presenting with the FAS/PFAS facial phenotypes (Face Rank 3 or 
4) across different patterns of quantity, frequency, and timing of prenatal alcohol exposure. 
Exposure to 1 to 4 drinks/wk on average during gestation was associated with a significant 
8.5-fold increased odds for presenting with the FAS/PFAS facial phenotypes compared to 
participants with no average drinks per week. Exposure to a single binge drinking episode 
was associated with a significant 1.9-fold increased odds for the FAS/PFAS facial 
phenotypes. When the timing of the single binge exposure was in gestational weeks 3 to 4, 
participants were 2.5-fold more likely to present with the FAS/PFAS facial phenotypes than 
participants with no binge exposure. Single binge exposures occurring before or after 
gestational weeks 3 to 4 did not result in a significantly increased odds of the FAS/ PFAS 
facial phenotypes.
Table 5 also presents the odds of presenting with each of the individual facial features of 
FAS (short PFL: ≤−2 SDs, ABC-Score = C), smooth philtrum (Rank 4 or 5, ABC-Score = 
C), and thin upper lip (Rank 4 or 5, ABC-Score = C) across the different patterns of prenatal 
alcohol exposure.
PFL.—The odds of presenting with short PFLs (ABC-Score = C) increased significantly 
from 1.8-fold to 3.7-fold as the average number of drinks per week during pregnancy 
increased from 1 to 4 to ≥5. The odds of short PFLs increased significantly as the timing of 
binge exposure occurred earlier in gestation. The odds were highest when binge(s) occurred 
in weeks 1 to 2 and lowest when binge(s) occurred during or after gestational week 5, 
although not statistically significant. The odds of short PFLs was highest with a single binge 
exposure and significantly lower with 2 or more binge episodes.
Philtrum.—Odds of a smooth philtrum (ABC-Score = C) appeared to be more dependent 
on the timing of binge exposure than the number of binge exposures. The odds were 
significant and highest (1.3-fold higher) when binge drinking occurred in weeks 1 to 2. Odds 
decreased linearly as binge drinking occurred later in gestation. Intake of 1 to 4 drinks/ wk 
on average and 2 binge episodes in early pregnancy were associated with significantly lower 
odds of a smooth philtrum.
Schiøler Kesmodel et al. Page 8
Alcohol Clin Exp Res. Author manuscript; available in PMC 2019 August 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Lip.—Odds of upper lip thinness (ABC-Score = C) also appeared to be more dependent on 
the timing of binge exposure rather than the number of binge exposures. Participants with 1 
binge exposure were at significantly higher odds (Odds ratios [OR] 1.19) for thin upper lip 
than participants with no binge exposures. When binge exposure occurred in weeks 3 to 4, 
odds of a thin upper lip was greatest (OR 1.66). When binge exposure occurred in week 5 or 
later, children were significantly less likely to present with a thin upper lip (OR 0.83).
Associations Between the Magnitude of Expression of the FAS Facial Phenotype and 
Other Diagnostic Features of FASD
Individuals with short PFLs (≤−2 SDs) had significantly lower mean FSIQ and PIQ scores 
(5 to 7 points lower) than the reference group with normal PFLs (>−1 SD) (Table 6). 
Individuals with smooth philtrums (Rank 4or 5) had significantly lower mean FSIQ and VIQ 
scores (3 to 4 points lower) than individuals with deep philtrums (Rank 1 or 2). Individuals 
with thin upper lip (Rank 4 or 5) had a significantly higher mean VIQ score (2.5 points 
higher) than individuals with thicker upper lips (Ranks 1 and 2). When the 3 facial features 
were assessed together, individuals with the Rank 3 or 4 FAS/PFAS facial phenotypes 
presented with mean FSIQ and PIQ scores that were 4 to 7 points lower than the individuals 
with normal facial phenotypes (Ranks 1 and 2). Although the magnitude and direction of 
association were equivalent to those observed for the individual facial features, the contrasts 
were not statistically significant. The smaller sample sizes resulted in insufficient power 
(<80%) to identify the 4 to 7 point contrasts as statistically significant.
We found no significant or clinically relevant differences between children with different 
facial phenotypes or different measures of individual facial features and executive function 
and attention (data not presented).
Mean birthweight, birth length, and birth head circumference decreased significantly with 
increasing magnitude of expression of the FAS facial phenotype (Face Ranks 1 to 4) among 
the 366 participants in Group A (Fig. 2).
DISCUSSION
Summary
There were 3 core findings in this study with a sample of 670 children in which 109 had no 
prenatal alcohol exposure and 561 had low-to-moderate exposure with isolated binge 
episodes. First, 10 children presented with the FAS/PFAS facial phenotypes (Face Rank 3 or 
4). All 10 were alcohol-exposed. None met the diagnostic criteria for FAS or PFAS at 5 
years of age. All 10, however, remain at risk for PFAS because they were too young at age 5 
years to engage in the battery of neuropsychological assessments required to confirm or rule 
out brain dysfunction. Second, children exposed to 1 to 4 drinks/wk were 8.5-fold more 
likely to present with the FAS/PFAS facial phenotypes (Rank 3 or 4) than children with no 
prenatal alcohol exposure. Risk of the FAS/PFAS facial phenotypes was also significantly 
increased (2.5-fold) among children with a single binge exposure in gestational weeks 3 to 4 
compared to children with no binge exposures. And third, the magnitude of expression of the 
FAS facial phenotype was significantly correlated with all other diagnostic features of FAS: 
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growth deficiency, microcephaly, and measures of CNS dysfunction, even if measures of 
these features were within the normal range in this sample.
A primary objective of this study was to determine whether adverse outcomes typically 
observed among populations with high PAE could be found in a population with much lower 
exposure. Since the facial features that define FAS/PFAS were measured using the same 
software (Astley, 2016), personnel, and FASD diagnostic system (Astley, 2004) used to 
measure facial features in the University of Washington FASDPN clinical population, 
relevant comparisons can be made between the 2 populations. The FASDPN dataset includes 
over 3,000 individuals with prenatal alcohol exposure who received an interdisciplinary 
FASD diagnostic evaluation using the FASD 4-Digit Diagnostic Code (Astley, 2010). The 
alcohol exposures reported in the current study population (83% reported no more than 1 to 
8 drinks/wk and/or isolated binge episode [drinking categories 1a to 4c; Table 1]) were 
considerably lower than the alcohol exposures reported in the FASDPN clinical population 
(76% report greater than 1 to 8 drinks/wk; average exposure is 7 to 9 drinks per occasion, 4 
to 5 d/wk) (Astley, 2010).
Prevalence of FAS Facial Features and Correlation with Prenatal Alcohol Exposure
In the current study population with low-to-moderate prenatal alcohol exposure, 3.2% 
(10/308) presented with the FAS/PFAS facial phenotypes (Rank 3 or 4). All were exposed to 
no more than 7 drinks/wk and no more than a single episode of binge drinking. In contrast, a 
much higher proportion of individuals (19%) present with the FAS/PFAS facial phenotypes 
in the FASDPN patient population (Astley, 2010). Although individuals in the FASDPN 
patient population are, on average, highly exposed, 1 of every 14 diagnosed with FAS/PFAS 
has a reported exposure of no more than 7 drinks/wk. This is similar to the 10 children with 
the FAS/PFAS facial phenotypes in the current study. Although prenatal alcohol exposure 
may have been underreported for these 1 in 14 cases, it is also possible that these children 
are particularly vulnerable to lower levels of exposure. Future research may want to examine 
this possibility. The outcomes in the current study suggest that lower exposures may, in fact, 
be sufficient to produce the FAS/PFAS facial phenotypes in a small proportion of children. 
Timing of exposure also appears to be important. Perhaps one of the most compelling 
findings in the current study was a significant 2.5-fold increased odds of the FAS/PFAS 
facial phenotypes among children with a single binge exposure in gestational weeks 3 to 4. 
Gestational weeks 3 and 4 reflect the primitive streak and gastrulation stage of 
embryogenesis—a critical period of induction of alcohol-induced craniofacial alterations 
(Astley, 2013; Astley et al., 1999; Sulik, 1984).
FAS and PFAS require more than just the Rank 3 or 4 facial phenotype. Although 10 
children in the current study presented with the Rank 3 or 4 FAS/PFAS facial phenotypes, 
none met the diagnostic criteria for FAS or PFAS (in accordance with the 4-Digit Code) at 
the young age of 5 years. FAS is defined by growth ≤10th percentile, a Rank 4 facial 
phenotype, and microcephaly (less than or equal to third percentile) and/or brain dysfunction 
(3 or more domains of brain function 2 or more SDs below the mean) (Astley, 2004). PFAS 
is defined by normal growth, a Rank 3 or 4 facial phenotype, and microcephaly and/or brain 
dysfunction (3 or more domains of brain function 2 or more SDs below the mean). Since no 
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child presented with growth ≤10th percentile, no child met the criteria for FAS. In contrast, 
all 10 children met the growth and facial criteria for PFAS. None of them presented with 
microcephaly; therefore, CNS dysfunction would be required to meet the CNS criteria for 
PFAS. Nevertheless, at 5 years of age, all were too young to participate in the battery of 
assessments required to confirm or rule out CNS dysfunction. As documented in the 
FASDPN clinical population, most children with FAS or PFAS do not present with severe 
brain dysfunction until later in childhood. For example, among 87 children ≤5 years of age 
at the time of their FAS/PFAS diagnosis at the FASDPN, only 24% met the criteria for 
severe CNS dysfunction (3 or more domains of function 2 or more SDs below the mean). 
Among 152 children >5 years of age at the time of their FAS/PFAS diagnosis, 84% met the 
criteria for severe CNS dysfunction. In addition, recent research (Astley et al., 2016) 
documents that 67 and 70% of young children with prenatal alcohol exposure that present 
with the Rank 3 or 4 FAS facial phenotypes, respectively, will present with severe CNS 
dysfunction (3 or more domains of brain function 2 or more SDs below the mean) when they 
are old enough (>8 years of age) to engage in more sophisticated assessments of brain 
function. Thus, if any of the 10 children with the Rank 3 or 4 FAS/PFAS facial phenotypes 
present with brain dysfunction (3 or more domains of brain function 2 or more SDs below 
the mean) later in childhood, they would meet the diagnostic criteria for PFAS.
Prenatal alcohol exposure was significantly correlated with the FAS facial phenotype and the 
3 individual features that comprise the FAS facial phenotype. The strongest correlations with 
alcohol (ORs of 1.9 to 8.5) were observed when the 3 features appeared together to produce 
the Rank 3 or 4 FAS/PFAS facial phenotypes (Table 5). Since the Rank 4 FAS facial 
phenotype is confirmed to be highly specific to prenatal alcohol exposure (Astley, 2013; 
Astley and Clarren, 1996), it is highly likely that the FAS/PFAS facial phenotypes observed 
in these 10 children were caused by their prenatal alcohol exposure. Weaker, but statistically 
significant, correlations (ORs of 1.2 to 3.7) were observed between prenatal alcohol 
exposure and each individual FAS facial feature. This would be expected since alcohol is not 
the only factor influencing the length of a palpebral fissure, the depth of a philtrum, or the 
thickness of an upper lip. Perhaps one of the strongest factors other than alcohol influencing 
the physical presentation of these 3 facial features is familial genetics. A unique strength of 
the current study was the opportunity to measure the birth mothers’ facial features. Among 
the 10 children who presented with the Rank 3 or 4 FAS facial phenotypes, all of their birth 
mothers presented with normal facial phenotypes (Face Ranks 1 and 2).
Correlations Between the FAS Facial Phenotype and Growth Deficiency, Microcephaly, and 
CNS Dysfunction
The correlations between face, growth, and CNS abnormalities observed in the current study 
(Fig. 2) are nearly identical to those documented in the FASDPN clinical population (figures 
8 and 9 in Astley, 2013). This study extends understanding of these correlations to a 
population of children with low-to-moderate prenatal alcohol exposure.
Strengths
The sample of women and children used for this study form part of a well-described, 
prospective cohort (Kesmodel et al., 2010; Olsen et al., 2001). While information bias is 
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always a potential problem in observational studies (Kesmodel, 2018), the risk of 
information bias was minimized. Information on alcohol drinking patterns was collected 
directly from the birth mothers during pregnancy using validated instruments (Kesmodel, 
2001; Kesmodel and Olsen, 2001), and all facial measures were performed by the inventor 
of the software system (Astley, 2016) used in this paper, thereby eliminating any 
interobserver variability and reducing the likelihood of measurement error. Further, facial 
measurements were taken blind to the child’s exposure history. Because of the detailed 
information available on all participants, confounding could be addressed by adjusting for a 
priori selected potential confounders (Howards, 2018), following the same criteria as 
previous papers based on this cohort (Kesmodel et al., 2012). Also, it has previously been 
shown that despite selection problems in the DNBC, the external validity of measures of 
association seems to be good (Nohr and Liew, 2018).
Weaknesses
The DNBC represents only approximately 30% of all Danish pregnant women and hence is 
not a representative sample (Olsen et al., 2001). Further, the LDPS sample is a stratified 
sample within the DNBC (Kesmodel et al., 2010), making the current sample even less 
representative of the background population. While such selection may make the sample less 
suitable for firm statements about the overall prevalence of specific traits, inferences based 
on measures of association have been shown to be valid within the cohort (Nohr and Liew, 
2018). Finally, since only 10 children presented with the Rank 3 to 4 facial phenotypes, the 
representativeness of this small group may be limited, but the statistical power was sufficient 
to identify significant associations with level and timing of prenatal alcohol exposure.
CONCLUSION
In conclusion, we found that approximately 3% (10/308) of the children whose mothers 
reported low-to-moderate alcohol intake, not usually associated with the full FAS, met the 
criteria for moderate-to-severe expression of the FAS facial phenotypes, Face Ranks 3 to 4. 
None met the diagnostic criteria for FAS or PFAS at 5 years of age. However, all 10 remain 
at risk for PFAS because they were too young at age 5 years to engage in the battery of 
neuropsychological assessments required to confirm or rule out severe brain dysfunction. 
The risk of FAS/PFAS facial phenotypes (Ranks 3 to 4) was significantly increased among 
both women with average alcohol intake of 1 to 4 drinks/wk and women with isolated 
episodes of binge drinking, particularly during gestational weeks 3 to 4. These findings 
suggest that low-to-moderate levels of prenatal alcohol exposure or isolated binge exposures 
may place some fetuses at risk for FAS, PFAS, or other FASDs. Thus, conservative advice is 
still for women to abstain from alcohol consumption during pregnancy.
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APPENDIX: DETAILED PROCEDURES FOR TAKING AND SELECTING 
PHOTOGRAPHS FOR FACIAL CODING:
To examine the association between facial features used to diagnose FAS/PFAS and low-to-
moderate prenatal alcohol exposure, digital photographs were obtained, selected, and 
categorized for FAS/PFAS criteria according to the FASD 4-Digit Code (Astley, 2004). 
Details of these procedures are described in this appendix.
Taking Digital Photographs
Each participant had a standardized frontal, oblique, and lateral digital facial photograph 
taken in accordance with the FAS Facial Photographic Analysis Software instructions 
(Astley, 2016). Briefly, the child had a relaxed facial expression (no smile, lips gently 
closed, eyes fully open with no eyeglasses), and the digital images had proper rotation, 
exposure, and focus. A 19.05-mm-diameter round paper sticker was placed between the 
participant’s eyebrows as an internal measure of scale. Photographs were taken according to 
the protocol outlined in Astley (2016), and lead psychologists received in-person training on 
how to take the photographs by SA.
Selection of Photographs for Facial Coding
Resources and photograph quality did not permit the complete analysis of all 1,628 
participants’ photographs. Thus, a stepwise approach was used to identify those children 
with clear or suggestive indication of facial dysmorphia for further measurement. The goal 
was to identify all individuals that presented with 1, 2, or all 3 of the FAS facial features as 
defined above. The photographs were measured by authors AG and SA in a 2-step process, 
masked to the participant’s alcohol exposure.
• Step 1: AG measured the PFLs and lip circularities of all 1,628 participants 
regardless of the quality of the feature in the photograph (e.g., the eyes were not 
fully open, the child was smiling, or the sticker curled). If the eyes are not fully 
open, the child is smiling, or the sticker is slightly curled, the direction of error 
will always be in 1 direction; the PFLs will be shorter, the lip thinner, and the 
philtrum smoother than they truly are. SA reviewed the subset from Step 1 that 
appeared to have short PFLs ≤−1.5 SDs and/or thin upper lips (lip circularities 
≥70) and identified the subset that had sufficient image quality to ensure the PFL 
and lip circularity measures could be accurately measured. SA then remeasured 
the PFLs and lip circularities of this subset to ensure the highest level of 
consistency and accuracy across all facial measures.
• Step 2: SA also reviewed the philtrum of all 1,628 participants and ranked only 
the subset with philtrum images of sufficient image quality and met criteria for 
Rank 4 or 5.
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Final FAS/PFAS Determination
For all viable photographs, whenever a participant was identified as having at least 1 facial 
feature in the FAS range, the other 2 facial features were also measured if the quality of the 
image was sufficient. Once measurement of the 3 facial features was complete, the software 
generated a 4-Digit Code Facial ABC-Score and Face Rank (Fig. 1). For example, if a child 
presented with PFLs 2.6 SDs below the mean, a Rank 3 philtrum, and a Rank 2 upper lip, 
they would receive a Facial ABC-Score of CBA and a Face Rank of 2 (mild). If 1 or 2 of the 
3 facial features could not be measured, an “X” was placed in the ABC-Score to signify its 
absence (e.g., the ABC-Score XCA signifies that the PFL could not be measured, but the 
philtrum was a “C” and the lip was an “A” [see Fig. 1B]). A Face Rank could not be 
generated if 1 or 2 of the 3 features could not be measured, but Facial ABC-Scores with 1 or 
2 missing features could be used to accurately rule out 1 or more of Face Ranks 1 to 4. For 
example, if a Facial ABC-Score was XXA, Face Ranks 3 and 4 can be accurately ruled out 
despite not knowing the outcome of the PFL or philtrum, because neither can include a 
feature with a Rank A.
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Fig. 1. 
(A) University of Washington Lip-Philtrum Guide 1 used to rank lip thinness and philtrum 
smoothness on 5-point Likert scales. (B) The face tables on the backside of the Lip-Philtrum 
Guide outline how the magnitude of expression of the FAS facial phenotype is ranked on a 
4-point scale (Rank 1: normal; Rank 2: mild; Rank 3: moderate; and Rank 4: severe) (Astley, 
2004). Copyright Susan Astley Hemingway. Reprinted by permission.
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Fig. 2. 
Mean birthweight, birth length, and birth head circumference decreased significantly with 
increasing magnitude of expression of the FAS facial phenotype (Face Ranks: 1, normal; 2, 
mild; 3, moderate; and 4, severe) among the 366 participants in Group A. Error bars reflect 
95% CIs. One-way ANOVA test for linear trend p-values: birth length 0.04, and birth-weight 
and head circumference 0.001.
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